Evidence map›Paper›PMID 26098775›Full record

ArticleOncotarget2015

Citrus limon-derived nanovesicles inhibit cancer cell proliferation and suppress CML xenograft growth by inducing TRAIL-mediated cell death.

Stefania Raimondo, Flores Naselli, Simona Fontana, Francesca Monteleone, Alessia Lo Dico, Laura Saieva, Giovanni Zito, Anna Flugy, Mauro Manno, Maria Antonietta Di Bella and 2 more

Registry-linked trialOpen access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04698447 (Effects of the Natural Supplement CitraVes Containing Nanovesicles Delivered From Citrus Limon), which is not on this map. Cited by 303 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
303citing papers in PubMed, 3 pooled it
4.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04698447 naunknown statusnot on this mapstarted 2019, after this paper: background citation

Effects of the Natural Supplement CitraVes Containing Nanovesicles Delivered From Citrus Limon (L.) Juice on Cardio-metabolic Risk Factors in Subjects With Metabolic Syndrome

TypeinterventionalSponsorUniversity of PalermoRan2019 to 2021Enrolled60ConditionsMetabolic Syndrome, Healthy VolunteersArmsNatural supplement containing nanovesicles delivered from Citrus Limon (L.) juice_MetS, Placebo (without any active ingredients), Natural supplement containing nanovesicles delivered from Citrus Limon (L.) juice_HS
3 · Its place in the literature

Who cites it

303 citing papers in PubMed, 3 syntheses or guidelines pooled it, 472 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Review
  6. Citrus limon-Derived Extracellular Vesicles Promote Hair Growth.Applied biochemistry and biotechnology · 2026
    Article
  7. Review
  8. Review
  9. Review
  10. Green nanomedicine for cancer therapy.Chinese medical journal · 2026
    Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Review
  20. Review

243 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Stefania RaimondoDipartimento di Biopatologia e Biotecnologie Mediche, Università degli Studi di Palermo, sezione di Biologia e Genetica, Palermo, Italy.
Flores NaselliDipartimento di Biopatologia e Biotecnologie Mediche, Università degli Studi di Palermo, sezione di Biologia e Genetica, Palermo, Italy.
Simona FontanaDipartimento di Biopatologia e Biotecnologie Mediche, Università degli Studi di Palermo, sezione di Biologia e Genetica, Palermo, Italy.
Francesca MonteleoneDipartimento di Biopatologia e Biotecnologie Mediche, Università degli Studi di Palermo, sezione di Biologia e Genetica, Palermo, Italy.
Alessia Lo DicoDipartimento di Biopatologia e Biotecnologie Mediche, Università degli Studi di Palermo, sezione di Biologia e Genetica, Palermo, Italy.
Laura SaievaDipartimento di Biopatologia e Biotecnologie Mediche, Università degli Studi di Palermo, sezione di Biologia e Genetica, Palermo, Italy.
Giovanni ZitoLaboratorio di Ingegneria Tissutale - Piattaforme Innovative per l'Ingegneria Tissutale (PON01-00829), Istituto Ortopedico Rizzoli, Palermo, Italy.
Anna FlugyDipartimento di Biopatologia e Biotecnologie Mediche, Università degli Studi di Palermo, sezione di Biologia e Genetica, Palermo, Italy.
Mauro MannoIstituto di Biofisica, Consiglio Nazionale delle Ricerche, Palermo, Italy.
Maria Antonietta Di BellaDipartimento di Biopatologia e Biotecnologie Mediche, Università degli Studi di Palermo, sezione di Biologia e Genetica, Palermo, Italy.
Giacomo De LeoDipartimento di Biopatologia e Biotecnologie Mediche, Università degli Studi di Palermo, sezione di Biologia e Genetica, Palermo, Italy.
Riccardo AlessandroDipartimento di Biopatologia e Biotecnologie Mediche, Università degli Studi di Palermo, sezione di Biologia e Genetica, Palermo, Italy.
University of Palermo · ITIstituto Ortopedico Rizzoli · ITNational Research Council · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nanosized vesicles are considered key players in cell to cell communication, thus influencing physiological and pathological processes, including cancer. Nanovesicles have also been found in edible-plants and have shown therapeutic activity in inflammatory bowel diseases; however information on their role in affecting cancer progression is missing.Our study identify for the first time a fraction of vesicles from lemon juice (Citrus limon L.), obtained as a result of different ultracentrifugation, with density ranging from 1,15 to 1,19 g/ml and specific proteomic profile. By using an in vitro approach, we show that isolated nanovesicles inhibit cancer cell proliferation in different tumor cell lines, by activating a TRAIL-mediated apoptotic cell death. Furthermore, we demonstrate that lemon nanovesicles suppress CML tumor growth in vivo by specifically reaching tumor site and by activating TRAIL-mediated apoptotic cell processes. Overall, this study suggests the possible use of plant-edible nanovesicles as a feasible approach in cancer treatment.

Indexed as

CitrusExosomesNanoparticlesAnimalsAntineoplastic Agents, PhytogenicApoptosisCell Line, TumorCell ProliferationCell SurvivalFruit and Vegetable JuicesHumansHuman Umbilical Vein Endothelial CellsLeukemia, Myelogenous, Chronic, BCR-ABL PositiveMaleMice, Inbred NODMice, SCIDAntineoplastic Agents, PhytogenicPlant ExtractsPlant ProteinsTNF-Related Apoptosis-Inducing LigandTNFSF10 protein, humancancerCitrus limon L.exosome-like nanovesiclesTRAIL-mediated cell death

Identifiers

PMID26098775
PMCPMC4637302
OpenAlexW1596011791

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.